TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press April 10, 1987
TCL Archive DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer November 9, 1984
